Skip to product information

OXALTERO 50MG INJ

Vendor: OXALTERO
Availability: In stock
Product type: Oncology
Composition: OXALIPLATIN
Strength: 50MG
Dosage Form: Injection

Prescription Required

Sale price  ₹ 700.00 Regular price  MRP: ₹ 2,345.00 70% OFF
Inclusive of all taxes.
OXALTERO 50MG INJ
Regular price ₹ 700.00
Regular price ₹ 2,345.00 Sale price ₹ 700.00 (-70%)
Strength: 50MG
Dosage Form: Injection
OXALTERO 50MG INJ
OXALTERO 50MG INJ
Sale price  ₹ 700.00 Regular price  MRP: ₹ 2,345.00 70% OFF

Introduction

Oxaltero 50mg Injection contains oxaliplatin, a platinum-based anticancer medicine that inhibits DNA replication in cancer cells.

Uses

Oxaltero 50mg Injection is used for the treatment of colorectal cancer.

  • Adjuvant colorectal cancer therapy
  • Metastatic colorectal cancer
  • Used in combination chemotherapy regimens

Storage

  • Store below 25°C.
  • Protect from light.
  • Do not freeze.

Safety Information

  • Regular monitoring of blood counts and neurological symptoms is recommended.

Possible Side Effects

Possible side effects may include:

  • Peripheral neuropathy
  • Nausea
  • Vomiting
  • Diarrhoea
  • Fatigue
  • Neutropenia

About RareMeds

We, at RareMeds, make a diligent attempt to deliver accurate, expert-drafted and thoroughly reviewed medicine-related information to our consumers. However, it should, by no means, be considered a substitute for a prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact, we detest any form of self-medication without expert advice.

The sole purpose of the information on our portal is to educate our consumers, which helps improve communication between a doctor and a patient. The information is by no means complete in its entirety and should not be used to diagnose or treat any medical condition.

No amount of information can replace the experience and expertise of a doctor; therefore, his/her advice always holds priority and should be followed appropriately.

Disclaimer

Oxaltero is a prescription anticancer medicine.

It should only be administered under specialist oncology supervision.

Related Products